Antiepileptic therapy in patients with central nervous system malignancies
More than 200,000 patients are diagnosed with primary or metastatic brain tumors each year in the United States. Of these patients, 20% to 40% will develop seizures at presentation, and another 20% to 40% will require treatment for seizures during their illness. Although the use of antiepileptic drugs (AEDs) in patients who have had seizures seems reasonable, the issue of prophylactic AED use for patients who have not had a seizure is an intensely debated subject. The American Academy of Neurology released a position statement in May 2000 addressing the use of anticonvulsants in newly diagnosed brain tumor patients who have never had a seizure. After a review of the literature, including all trials showing class I evidence, multivariate analysis using calculated odds ratios failed to show a prophylactic benefit of preventing a first seizure versus the risk of side effects and recommended not using prophylactic anticonvulsants in newly diagnosed patients with brain tumor. Despite this recommendation, a recent survey of the American Association of Neurologic Surgeons revealed that most neurosurgeons still use anticonvulsants prophylactically in patients with brain tumor. This review mainly includes primary brain tumors, but most of the concepts are transferable to patients with metastatic tumors.
KeywordsBrain Tumor Gabapentin Lamotrigine Topiramate Pregabalin
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References and Recommended Reading
Primary Brain Tumors in the United States: Statistical Report
. Chicago, IL: Central Brain Tumor Registry of the United States; 1997–2001.Google Scholar
Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics
. Cancer J Clin
Glantz MJ, Cole BF, Forsyth PA, et al.
: Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: report of the quality standards subcommittee of the American Academy of Neurology
:1886–1893. Required reading for anyone prescribing anticonvulsants.PubMedGoogle Scholar
Sirven JI, Wingerchuk DM, Drazkowski JF, et al.
: Seizure prophylaxis in patients with brain tumors: a meta-analysis
. Mayo Clin Proc
Sirven JI: Classifying seizures and epilepsy: a synopsis
. Semin Neurol
:237–246. Excellent review of seizure classification.PubMedCrossRefGoogle Scholar
French JA, Kanner AM, Bautista J, et al.
: Efficacy and tolerability of the new antiepileptic drugs, I: treatment of new-onset epilepsy: report of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society
French JA, Kanner AM, Bautista J, et al.
: Efficacy and tolerability of the new antiepileptic drugs, II: treatment of new-onset epilepsy: report of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society
:401–409. Provides practice parameters to help guide decision making in treatment.PubMedCrossRefGoogle Scholar
Kessler RC, Bavis RB, Foster DF, et al.
: Long-term trends in the use of complimentary and alternative medical therapies in the United States
. Ann Intern Med
Eisenbery DM, Davis RB, Ettner SL, et al.
: Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey
Hariharan S, Landol. J, More J, et al.
: Alternative therapy use by malignant glioma patients: data from the glioma outcomes project
Chang SM, Parney IF, Haung MS, et al.
: Patterns of care for adults with newly diagnosed malignant glioma
:557–564. This is an excellent up-to-date analysis of practice patterns for newly diagnosed high-grade gliomas from a multi-institutional study.PubMedCrossRefGoogle Scholar
Verhoef MJ, Hagan N, Pelletier G, Forsyth P: Alternative therapy use in neurologic diseases: use in brain tumor patients
Plunkett M, Klein E, Alldredge B: Use of complimentary and alternative medicine products by patients with epilepsy
. How common is it? Epilepsia
Khoi DT, Kossoff EH, Rubenstrein JE, et al.
: Can you predict immediate, complete, and sustained response to the ketogenic diet
Nebeling LC, Miraldi F, Shurin SB, Lerner E: Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports
. J Am Coll Nutr
Cole AJ: Initial individualized selection of long-term anticonvulsants drugs by neurologists
Vecht CJ, Wagner GL, Wilms EB: Treating seizures in patients with brain tumors: drug interactions between antiepileptic and chemotherapeutic agents
. Semin Oncol
Perry JR, Sawaka C: Add-on gabapentin for refractory seizures in patients with brain tumors
. Can J Neurol Sci
Newton HB, Goldlust S, Pearl D: Retrospective analysis of levetiracetam for the treatment of seizures in brain tumor patients
Larson SE, Sirven JI, Drazkowski JF, Zimmerman RS: Efficacy and tolerability of levetiracetam in patients with brain tumors and seizures
Penovch PE, Dickens DL, Gates JR, et al.
: Treating seizures due to brain neoplasms: rational new choices
Wagner GL, Wilms EB, Van Donselaar CA, Vecht CHJ: Levetiracitam: preliminary experience in patients with primary brain tumors
Stevens GH, Vogelbaum MA, Suh JH, et al.
: Levetiracetam use in brain tumor patients
Wrighton SA, Stevens JC: The human hepatic cytochromes P450 involved in drug metabolism
. Crit Rev Toxicol
Nelson DR, Koymans L, Kamataki T, et al.
: P450 super family: update on new sequences, gene mapping, accession numbers and nomenclature
Gilbert MR, Supko JG, Batchelor T, et al.
: Phase I clinical trial and pharmacokinetics study of irinotecan in adults with recurrent malignant glioma
. Clin Cancer Res
Fetell MR, Grossman SA, Fischer JD, et al.
: Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions
. J Clin Oncol
Bourg V, Lebrun C, Chichmahian RM, et al.
: Nitrosoureacisplatinum based chemotherapy associated with valproate: increase of haematologic toxicity
. Ann Oncol
Bittigua P, Sifringer M, Genz K, et al.
: Antineoplastic drugs and apoptotic neurodegeneration in the developing brain
. Proc Natl Acad Sci U S A
Jaeckle K, Ballman K, Uhm J, et al.
: Relationship of administration of enzyme-inducing anticonvulsants (EIAC) to survival in patients with glioblastoma: a North Central Cancer treatment Group (NCCTG) study
Chalifoux R, Elisevich K: Effect on ionizing radiation on partial seizures attributable to malignant cerebral tumors
. Stereotact Funct Neurosurg
Rogers L, Morris H, Lupica K: Effect of cranial irradiation on seizure frequency in adults with low grade astrocytomas and medically intractable epilepsy
Hwang SL, Lin CL, Lee KS, et al.
: Factors influencing seizures in adult patients with supratentorial astrocytic tumors
. Acta Neurochir (Wein)
Regis J, Bartolomei F, Rey M, et al.
: Gamma knife surgery for mesial temporal lobe epilepsy
. J Neurosurg
Regis J, Rey M, Bartolomei F, et al.
: Gamma knife surgery in mesial temporal lobe epilepsy: a prospective multicenter study
Wyllie ER, Luders H, Morris HH III, et al.
: Clinical outcome after complete or partial resection for intractable epilepsy
Berger MS, Ghatan S, Haglund MM, et al.
: Low grade gliomas associated with intractable epilepsy: seizure outcome utilizing electrocorticography during tumor resection
. J Neurosurg
Wen PY, Marks PW: Medical management of patients with brain tumors
. Curr Opin Oncol
Jooma R, Yeh HS, Privitera MD, Gartner M: Lesionectomy versus electrophysiologically guided resection for temporal lobe tumors manifesting with complex partial seizures
. J Neurosurg
Labar D, Murphy J, Tecoma E: Vagus nerve stimulation for medication-resistant generalized epilepsy
. EO4 Study Group Neurology
Karceski S: Devices in the treatment of epilepsy
. Semin Neurol
Ng M, Devinsky O: Vagus nerve stimulation for refractory idiopathic generalized epilepsy
Wilder BJ: Vagal nerve stimulation
. In Epilepsia: A Comprehensive Textbook
. Edited by Engle JJr, Pedley TA. Philadelphia: Lippincott-Raven; 1997:1353–1358.Google Scholar
Fischer RS, Mirski M, Krauss G: Brain stimulation
. In Epilepsy: A Comprehensive Textbook
. Edited by Engle JJr, Pedley TA Philadelphia: Lippincott-Raven; 1997:1867–1875.Google Scholar
Fischer RS, Uematsu S, Kraus GL, et al.
: Placebo-controlled pilot study of centromedian thalamic stimulation in treatment of intractable seizures
Bergey GK, Britton JW, Cuscino GD, et al.
: Implementation of an external responsive neurostimulator in patients with intractable epilepsy undergoing intracranial seizure monitoring
Kubota F, Kifune A, Shibata N, et al.
: Bone mineral density of epileptic patients on long-term antiepileptic drug therapy: a quantitative digital radiography study
. Epilepsy Res
Hahn TJ, Birge SJ, Scara CR, et al.
: Phenobarbital induced alterations in vit D metabolism
. J Clin Invest
Ensrund WE, Walczak TS, Blackwell T: Antiepileptic drug use increases rates of bone loss in older women: a prospective study
© Current Science Inc 2006